CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larsen, U. T.
Right arrow Articles by de Fine Olivarius, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larsen, U. T.
Right arrow Articles by de Fine Olivarius, B.

Canadian Journal of Anesthesia, Vol 36, 418-422, Copyright © 1989 by Canadian Anesthesiologists' Society

ARTICLES

Complications during anaesthesia in patients with Duchenne's muscular dystrophy (a retrospective study)

UT Larsen, B Juhl, O Hein-Sorensen and B de Fine Olivarius
Department of Anesthesiology, University Hospital of Aarhus, Denmark.

The purpose of this retrospective study was to estimate the frequency and severity of anaesthetic complications in patients with Duchenne's muscular dystrophy (DMD). Forty-four boys with DMD were exposed to anaesthesia and surgery 84 times during a period of 22 years (1965-86). The procedures took place at 15 different hospitals. Retrospective examination of the case records showed: 19 cases with local analgesia without any complications, and 18 of 65 general anaesthetics with minor or more serious complications. In ten cases an increase in body temperature above 37.5 degrees C was seen, five had abdominal pain and dark-coloured urine after surgery, and three had a critical perioperative course with a resemblance to malignant hyperthermia. The complications were almost exclusively related to the use of succinylcholine. The use of succinylcholine was dispersed through all ages. Three out of the eight patients with severe complications occurred 1.5, 2.5 and 4 years before the neuromuscular disease was diagnosed. Thus an unusual course of anaesthesia in male children calls for further investigation. Although it has been stated before that succinylcholine is contraindicated in patients with Duchenne's muscular dystrophy, the drug continues to be used.


This article has been cited by other articles:


Home page
 ChestHome page
D. J. Birnkrant, H. B. Panitch, J. O. Benditt, L. J. Boitano, E. R. Carter, V. A. Cwik, J. D. Finder, S. T. Iannaccone, L. E. Jacobson, G. L. Kohn, et al.
American College of Chest Physicians Consensus Statement on the Respiratory and Related Management of Patients With Duchenne Muscular Dystrophy Undergoing Anesthesia or Sedation
Chest, December 1, 2007; 132(6): 1977 - 1986.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
W. Schummer, C. Schummer, J. A. Hayes, W. A. Ames, G. N. Schmidt, M.-A. Burmeister, F. Wappler, and P. Bischoff
Acute heart failure during spinal surgery in a boy with Duchenne muscular dystrophy
Br. J. Anaesth., January 1, 2004; 92(1): 149 - 150.
[Full Text] [PDF]

Home page
 Br J AnaesthHome page
G. N. Schmidt, M.-A. Burmeister, C. Lilje, F. Wappler, and P. Bischoff
Acute heart failure during spinal surgery in a boy with Duchenne muscular dystrophy
Br. J. Anaesth., June 1, 2003; 90(6): 800 - 804.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
G. A. Frankowski, J. O. Johnson, and J. D. Tobias
Rapacuronium Administration to Two Children with Duchenne's Muscular Dystrophy
Anesth. Analg., July 1, 2000; 91(1): 27 - 28.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the Canadian Anesthesiologists' Society.